[1]
Ahmed El-Sayed Nour El-Deen et al. 2022. STUDY OF THE EFFECT OF TREATMENT WITH THE RENIN-ANGIOTENSIN SYSTEM INHIBITOR LOSARTAN AND THE LIPID-LOWERING DRUG ATORVASTATIN AND THEIR INTERACTIONS IN DIABETIC RATS. Journal of Population Therapeutics and Clinical Pharmacology. 29, 5 (Dec. 2022), 38–50. DOI:https://doi.org/10.53555/jptcp.v29i5.6563.